Zhong-Jie Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhong-Jie Zhao has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Bei Sun
Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
2 shared publications - Gang Wang
The First Affiliated Hospital of Harbin Medical University
2 shared publications - Guangquan Zhang
Department of Orthopedics, The Fourth Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China
2 shared publications - Hongze Chen
Department of Hepatobiliary and Pancreas Surgery, The First Affiliated Hospital of Harbin Medical University
2 shared publications - Le Li
Department of Pancreatic and Biliary Surgery The First Affiliated Hospital of Harbin Medical University Harbin China
2 shared publications - Rui Kong
The First Affiliated Hospital of Harbin Medical University 1 Department of Pancreatic and Biliary Surgery Harbin, China
2 shared publications
Latest Publications
- Open Access
- 25 October 2021
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (11) , 1-11
Lnc-PFAR facilitates autophagy and exacerbates pancreatic fibrosis by reducing pre-miR-141 maturation in chronic pancreatitis
Chronic pancreatitis (CP) is described as progressive inflammatory fibrosis of pancreas, accompanied with irreversible impaired endocrine and exocrine insufficiency. Pancreatic stellate cells (PSCs) are widely distributed in the stroma of the pancreas and PSCs activation has been shown as one of the leading causes for pancreatic fibrosis. Our previous study has revealed that autophagy is dramatically activated in CP tissues, which facilitates PSCs activation and pancreatic fibrosis. Long non-coding RNAs (LncRNAs) have been recognized as crucial regulators for fibrosis-related diseases. LncRNAs interact with RNA binding protein or construct competitive endogenous RNA (ceRNA) hypothesis which elicited the fibrotic processes. Until now, the effects of lncRNAs on PSCs activation and pancreatic fibrosis have not been clearly explored. In this study, a novel lncRNA named Lnc-PFAR was found highly expressed in mouse and human CP tissues. Our data revealed that Lnc-PFAR facilitates PSCs activation and pancreatic fibrosis via RB1CC1-induced autophagy. Lnc-PFAR reduces miR-141 expression by suppressing pre-miR-141 maturation, which eventually upregulates the RB1CC1 and fibrosis-related indicators expression. Meanwhile, Lnc-PFAR enhanced PSCs activation and pancreatic fibrosis through trigging autophagy. Our study interrogates a novel lncRNA-induced mechanism in promoting the development of pancreatic fibrosis, and Lnc-PFAR is suggested to be a prospective therapeutic target in clinical scenarios.
- 25 October 2021
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (11) , 1-11
Open AccessLnc-PFAR facilitates autophagy and exacerbates pancreatic fibrosis by reducing pre-miR-141 maturation in chronic pancreatitis
Chronic pancreatitis (CP) is described as progressive inflammatory fibrosis of pancreas, accompanied with irreversible impaired endocrine and exocrine insufficiency. Pancreatic stellate cells (PSCs) are widely distributed in the stroma of the pancreas and PSCs activation has been shown as one of the leading causes for pancreatic fibrosis. Our previous study has revealed that autophagy is dramatically activated in CP tissues, which facilitates PSCs activation and pancreatic fibrosis. Long non-coding RNAs (LncRNAs) have been recognized as crucial regulators for fibrosis-related diseases. LncRNAs interact with RNA binding protein or construct competitive endogenous RNA (ceRNA) hypothesis which elicited the fibrotic processes. Until now, the effects of lncRNAs on PSCs activation and pancreatic fibrosis have not been clearly explored. In this study, a novel lncRNA named Lnc-PFAR was found highly expressed in mouse and human CP tissues. Our data revealed that Lnc-PFAR facilitates PSCs activation and pancreatic fibrosis via RB1CC1-induced autophagy. Lnc-PFAR reduces miR-141 expression by suppressing pre-miR-141 maturation, which eventually upregulates the RB1CC1 and fibrosis-related indicators expression. Meanwhile, Lnc-PFAR enhanced PSCs activation and pancreatic fibrosis through trigging autophagy. Our study interrogates a novel lncRNA-induced mechanism in promoting the development of pancreatic fibrosis, and Lnc-PFAR is suggested to be a prospective therapeutic target in clinical scenarios.
- Open Access
- 30 September 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (44) , 71773-71781
Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer
Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer
- 30 September 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (44) , 71773-71781
Open AccessPlasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer
Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer